Cortexin effectiveness in circulatory encephalopathy
Khavinson VKh, Morozov VG, Rybnikov VIu, Zakutskiĭ NG · 1999 · Klin Med (Mosk) 77(4):42-45. PMID 10356917
What does this source report?
Reports neurological and cognitive changes with nasal-electrophoresis delivery alongside standard care.
- Population and setting
- 76 patients with dyscirculatory encephalopathy: 45 adjunctive Cortexin, 31 standard care
- Evidence type
- Human comparative study
- Preparation
- See the original report; formulation details require verification.
- Source language
- Russian
- Title provenance
- Title as recorded in the linked source or index. A separate original-language title has not been transcribed unless shown above.
What are the limitations?
- The abstract does not establish randomization or blinding.
- Delivery route and clinical population differ from other Cortexin reports.
Publication counts are not counts of independent trials. Reviews, translations and reports sharing participants may overlap. Findings apply to the studied preparation, population and endpoints.
Source access and review scope
Indexed abstract and citation checked via Europe PMC / PubMed; full methods and risk of bias not appraised.
Recorded source-check date: 2026-09-29. This date does not imply a completed systematic review.
Cite and trace this record
Original source: Khavinson VKh, Morozov VG, Rybnikov VIu, Zakutskiĭ NG. Cortexin effectiveness in circulatory encephalopathy Klin Med (Mosk) 77(4):42-45. PMID 10356917 1999.
Molekul research summary: https://molekul.io/research/bio-10356917. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.
Bibliography entry